Bayer plans USD 2.20 billion Ohio site. Bayer stock sits 15.19 percent below its 52-week high

Published on 10/28/2026 at 09:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The first module is planned for 2031, with 600 jobs. Bayer stock costs EUR 45.73 on October 28, 2026, 0.91 percent below Xetra close.

Pharmaceutical capacity and dates

On October 2, 2026, Bayer announced a USD 2.20 billion pharmaceutical site in Ohio.
The project targets 600 high-value jobs and 1,500 construction jobs.
Bayer stock trades at EUR 45.73 at 9:17 a.m. CET at Lang & Schwarz on October 28, 2026, 0.91 percent below the Xetra close of October 27, 2026.
Bayer will publish third-quarter results on November 3, 2026, at 7:30 a.m. CET.

Bayer, DE000BAY0017, Illustration mit AI erstellt.

Bayer (ISIN DE000BAY0017) plans a USD 2.20 billion pharmaceutical manufacturing site in Ohio, according to the company's Bayer release dated October 2, 2026. The project adds a long-term capacity angle to the stock while Bayer prepares for third-quarter results. At 9:17 a.m. CET on October 28, Bayer stock was trading at EUR 45.73 at Lang & Schwarz, 0.91 percent below the Xetra close of October 27, 2026 at EUR 46.15.

Why Ohio matters

The New Albany site is planned to support drug substance and drug product manufacturing for Bayer's oncology, cardiovascular and renal portfolio. The first module is expected to become operational in 2031, with a second module planned for 2034, according to Bayer's October 2 announcement.

Bayer expects the project to create 600 high-value jobs and 1,500 construction jobs. The company also said the investment builds on more than USD 7.00 billion spent on U.S. pharmaceutical research and manufacturing during the previous five years.

What does the investment add?

The project gives Bayer a manufacturing expansion with a stated commercial horizon rather than an immediate earnings contribution. Its scale is material beside the company's reported fiscal 2025 sales of EUR 45.60 billion, but the Ohio site is scheduled to develop over several years.

Next dates and stock context

Bayer's official investor-events page states that third-quarter 2026 results will be published on November 3, 2026, at 7:30 a.m. CET, followed by an investor call at 2:00 p.m. CET. The stock's EUR 45.73 quote is 15.19 percent below its EUR 53.92 52-week high, based on the same market snapshot.

Capacity meets valuation

The Ohio investment offers a measurable strategic commitment, while the share price remains below its yearly high. The next results will provide the nearer test of operating performance.

The further course of trading is shown by the continuously updated real-time quote of Bayer stock.